1. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients;Torriani;N Engl J Med,2004
2. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons;Chung;N Engl J Med,2004
3. Nunez M, Miralles C, Berdun MA, Aguirrebengoa K, Ocampo A, Losada E, et al., the PRESCO group. The PRESCO study: role of extended therapy and/or optimal doses of ribavirin in the treatment of chronic hepatits C in HIV-infected patients. 46th ICAAC, San Fransisco, 2006.
4. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial;Carrat;JAMA,2004
5. Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART;Cargnel;Antivir Ther,2005